Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Koosam, V. K.
- Evaluation of Methodologies of Physical Activity: self Reported International Physical Activity Questionnaires (IPAQ) Categories and Accelerometer Registration, as an E-health Tool
Abstract Views :368 |
PDF Views:219
Authors
Affiliations
1 Department of Biomedicine and Bioinformatics, Orebro University, 70182, SE
1 Department of Biomedicine and Bioinformatics, Orebro University, 70182, SE
Source
Indian Journal of Medicine and Healthcare, Vol 2, No 6 (2013), Pagination: 266-270Abstract
The aim of the study is to assess moderate level physical activity in male and female population, analyze the intra individual physical activities, compare for any significant variations in self reported, International Physical Activity Questionnaires (IPAQ) categories and Accelerometer registration, as an e-health tool. Reliability, precision and validity of both methodologies are also studied. Discusses the importance of Physical activity in minimizing the risk factors of various non communicable diseases, and impact on mortality and morbidity. Both the methodologies were studied in N = 38 participants, Further statistical analysis is performed by SPSS (Version 17.0) software. The analysis indicated that the self reported scores are less reliable and exaggerated, and in the moderate level physical activity there is no significant difference in male and female of population.Keywords
Physical Activity, Accelerometer, IPAQ, E-healthFull Text
References
- The global burden of disease: World Health Organization, Geneva, (2008). Available from: www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf
- Caspersen C J, Powell K E et al. (1985). Physical activity, exercise and Physical fitness: definitions and distinctions for health-related research, Public Health Report, vol 100(2), 126–131.
- Blair S N, and Kohl H W III et al. (1989). Physical fitness and all-cause mortality: a prospective study of healthy men and women, JAMA, vol 262(17), 2395–2401.
- Global Recommendation on Physical Activity for Health, World Health Organization, Geneva (2010), Available from: www.whqlibdoc.who.int/publications/2010/9789241599979_eng.pdf
- The benefits of physical exercises. World Health Organization, Available from: www.who.int/diet physical activity/factsheet_benefits/en/print.html
- Trost S G, McIver K L et al. (2005). Conducting accelerometer-based activity assessments in field-based research, Medicine & Science in Sports & Exercise (11 Suppl), S531–S543.
- The ActiGraph GT1M:GT1M specifications, Available from: www.theactigraph.com
- Warren J M, Ekelund U et al. (2010). Assessment of physical activity - a review of methodologies with reference to epidemiological research: a report of the exercise physiology section of the European Association of Cardiovascular Prevention and Rehabilitation, European Journal of Cardiovascular Prevention and Rehabilitation, vol 17(2), 127–139.
- Guidelines for the data processing and analysis of the International Physical Activity Questionnaire, Available from: www.ipaq.ki.se
- Craig C L, Marshall A L et al. (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine & Science in Sports & Exercise, vol 35(8), 1381–1395.
- Freedson P S, Melanson E et al. (1998). Calibration of the computer science and applications, Inc. accelerometer, Medicine & Science in Sports & Exercise, vol 30(5), 777–781.
- E-health: World Health Organization, Geneva, (2008). Available from: http://www.who.int/trade/glossary/story021/en/
- Overview on Strokes
Abstract Views :337 |
PDF Views:357
Authors
Affiliations
1 Department of Biomedicine and Methods in Medical Diagnostics, Orebro University-70182, SE
1 Department of Biomedicine and Methods in Medical Diagnostics, Orebro University-70182, SE
Source
Indian Journal of Medicine and Healthcare, Vol 2, No 7 (2013), Pagination: 275-280Abstract
Stroke is sudden death of brain cells due to lack of oxygen due to blood supply blockage or rupture of arteries of the brain. WHO indicates Stroke as the second leading cause for global mortality. Stroke is categorised into subtypes based on aetiology, assisting treatment evaluation. Risk factors for stroke are age, race, heredity, hypertension, diabetes, smoking, alcohol consumption, obesity, cholesterol. Prevention methods involve lifestyle modifications, low cholesterol diet, physical activity, minimising risk factors like cigarette smoking and alcohol consumption. Pharmacological treatments for hypertension, diabetes and interventional procedures are suggested. The prognosis depends on type extent, severity, duration of stroke and co-morbid risk factors. Timely management of stroke, pre-hospital stroke care minimise mortality rate and enhances survival rates. Life style modifications, decrease the recurrence, thereby decrease the economic burden of stroke.Keywords
Stroke, Pathophysiology of Stroke, Classification of Stroke, Risk Factors of Stroke, Treatment of StrokeFull Text
References
- Ballinger A, and Patchett S (2007). Essentials of Kumar and Clark clinical medicine, 4th Edn., Elsevier Saunders, 725–733.
- WHO, Stroke, Cerebrovascular accident, Available from: http://www.who.int/topics/cerebrovascular_accident/en/
- WHO, Global burden of stroke, Available from: http://www.who.int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf
- Truelsen T, Piechowski-Jóźwiak B et al. (2006). Stroke incidence and prevalence in Europe: a review of available data, European Journal of Neurology, vol 13(6), 581–598.
- WHO Stroke, Available from: http://www.who.int/ncd_surveillance/ncds/strokerationale/en/
- Green A R (2008). Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly, vol 153, Suppl 1, S325–S338.
- Jovićević M, Divjak I et al. (2010). Non-atherosclerotic arteriopathy as the cause of ischemic stroke among young adults. Medicinski pregled, vol 63(5–6), 324–332.
- Elkind M S (2010). Inflammatory mechanisms of stroke, Stroke, vol 41(10 Suppl), S3–S8.
- Fuster V, Stein B et al. (1990). Atherosclerotic plaque rupture and thrombosis, Evolving concepts. Circulation, vol 82(3 Suppl), II47–II59.
- Broussalis E, Killer M et al. (2011). Current therapies in ischemic stroke, Part A, Recent developments in acute stroke treatment and in stroke prevention, Drug Discovery Today.
- Sacco R L (1997). Wolf PA, American Heart Association Prevention Conference, IV. Prevention and Rehabilitation of Stroke, Risk factors, Stroke, (7), 507–517.
- He J, Klag M J et al. ( 1995). Stroke in the People’s Republic of China, I. Geographic variations in incidence and risk factors, Stroke, (12), 2222–2227.
- Howard G, Cushman M et al. (2011 ). for the Reasons for geographic and racial differences in stroke (regards) investigators, Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass, (12), 3369–3375.
- Muthaian R, Minhas G et al. (2011). Pathophysiology of stroke and stroke induced retinal ischemia: Emerging role of stem cells. Journal of Cellular Physiology, doi: 10.1002/jcp.23048 [Epub ahead of print].
- O’Donnell M J, Xavier D et al. (2010). Interstroke investigators.
- Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the Interstroke study): a case-control, Lancet, vol 376(9735), 112–123.
- Kolominsky-Rabas P L et al. (2001) Epidemiology of ischemic stroke subtypes according to Toast criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study, vol 32(12), 2735–2740.
- Sumer M M, and Erturk O (2002). Ischemic stroke subtypes: risk factors, functional outcome and recurrence, Neurological Sciences, vol 22(6), 449–454.
- Shang W Y, and Liu J Y (2011). Stroke subtype classification: a comparative study of ASCO and modified TOAST, Journal of the Neurological Sciences.
- Han S W, Kim S H et al. (2007). A new subtype classification of ischemic stroke based on treatment and etiologic mechanism, vol 57(2), 96–102.
- Bardutzky J, and Schwab S (2007). Antiedema therapy in ischemic stroke, Stroke, vol 38(11), 3084–3094.
- Paciaroni M, and Bogousslavsky J (2010). Primary and secondary prevention of ischemic stroke, European Neurology, vol 63(5), 267–278.
- Bergman D (2011). Preventing recurrent cerebrovascular events in patients with stroke or transient ischemic attack: The current data, Journal of the American Academy of Nurse Practitioners, vol 23(12), 659–666, DOI: 10.1111/j.1745-7599.2011.00650.x
- Kessler C, Khaw AV et al. (2011). Standardized prehospital treatment of stroke, Deutsches Ärzteblatt international, 108(36), 585–591.
- Walter S, Kostpopoulos P et al. (2010). Bringing the hospital to the patient: first treatment of stroke patients at the emergency site, PLoS One, vol 5(10), e13758.
- Bae H J, Kim D H et al. (2010). Prehospital notification from the emergency medical service reduces the transfer and intra-hospital processing times for acute stroke patients, The Journal of Clinical Neurology, vol 6(3), 138–142.
- Evenson K R, Foraker R E et al. (2009). A comprehensive review of prehospital and in-hospital delay times in acute stroke care, International Journal of Stroke, vol 4(3),187–199.
- Muthaian R, Minhas G et al. (2011). Pathophysiology of stroke and stroke induced retinal ischemia: Emerging role of stem cells, Journal of Cellular Physiology, DOI: 10.1002/ jcp.23048
- Mayberg M R, Wilson S E et al. (1991). Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis, Veterans Affairs Cooperative Studies Program 309 Trialist Group, JAMA, vol 266(23), 3289–3294.
- European Carotid Surgery Trialists’ Collaborative Group (1991). MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis, European Carotid Surgery Trialists’ Collaborative Group, Lancet, vol 337(8752), 1235–1243.
- North American Symptomatic Carotid Endarterectomy Trial Collaborators (1991). Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis, North American Symptomatic Carotid Endarterectomy Trial Collaborators, The New England Journal of Medicine, vol 325(7), 445–453.
- Barnett H J, Taylor D W et al. ( 1998). Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators, The New England Journal of Medicine, vol 339(20), 1415–1425.
- Storey G S, Marks M P et al. (1996). Vertebral artery stenting following percutaneous transluminal angioplasty, Technical note, Journal of Neurosurgery, vol 84(5), 883–887.
- Sacco R L, Adams R et al. (2006). American Heart Association/American Stroke Association Council on Stroke, Council on Cardiovascular Radiology and Intervention, American Academy of Neurology, Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline, Circulation, vol 113(10), e409–449.
- ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002). The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), JAMA, vol 288(23), 2981–2997.
- Tuomilehto J, Rastenyte D et al. (1999). Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators, The New England Journal of Medicine, vol 340(9), 677–684.
- Amarenco P, and Tonkin A M (2004). Statins for stroke prevention: disappointment and hope, Circulation, vol 109(23 Suppl 1), III44–III49.
- Rubins H B, Davenport J et al. (2001). VA-HIT Study Group. Reduction in stroke with gem fibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT), Circulation, vol 103(23), 2828–2833.
- Rexrode K M, Hennekens C H et al. (1997). A prospective study of body mass index, weight change, and risk of stroke in women, JAMA, vol 277(19), 1539–1545.
- DiPietro L, Ostfeld A M et al. (1994). Adiposity and stroke among older adults of low socioeconomic status: the Chicago Stroke Study, American Journal of Public Health, vol 84(1), 14–19.
- Lee I M, Hennekens C H et al. (1999). Exercise and risk of stroke in male physicians, Stroke, vol 30(1), 1–6.
- Hu F B, Stampfer M J et al. (2000). Physical activity and risk of stroke in women, JAMA, vol 283(22), 2961–2967.
- Lee C D, Folsom A R et al. (2003). Physical activity and stroke risk: a meta-analysis, vol 34(10), 2475–2481.
- Kokkinos P F, Narayan P et al. (1995). Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-Americanmen with severe hypertension, The New England Journal of Medicine, vol 333(22), 1462–1467.
- Endres M, Gertz K et al. ( 2003). Mechanisms of stroke protection by physical activity, Annals of Neurology, vol 54(5), 582–590.
- Ezekowitz M (1998). Antithrombotics for left-ventricular impairment? Lancet, vol 351(9120), 1904.
- Cleland J G, Findlay I et al. (2004). The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithromboticstrategies for patients with heart failure, American Heart Journal, vol 148(1), 157–164.
- Massie B M, Krol W F et al. (2004). The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics, Journal of Cardiac Failure, vol 10(2), 101–112.
- Barnett H J, Jones M W et al. (1976). Cerebral ischemic events associated with prolapsing mitral valve, Archives of Neurology, vol 33(11), 777–782.
- Fiorelli M, Bastianello S et al. ( 1999). Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort, vol 30(11), 2280–2284.
- Ananthasubramaniam K, Beattie J N et al. (2001). How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patientshospitalized with a major hemorrhage? Chest Journal, vol 119(2), 478–484.
- Eckman M H, Rosand J et al. (2003). Greenberg SM. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis, vol 34(7), 1710–1716.
- Campbell N R, Hull R D et al. (1996). Aging and heparin-related bleeding, Archives of Internal Medicine, vol 156(8), 857–860.
- Glazier R L, and Crowell E B (1976). Randomized prospective trial of continuous vs intermittent heparin therapy, JAMA, vol 236(12), 1365–1367.
- Stroke Prognosis: What You Should Know, Available from: http://www.caring.com/articles/stroke-prognosis
- Overview of Confocal Microscopy and Usage in Cystic Fibrosis
Abstract Views :335 |
PDF Views:314
Authors
Affiliations
1 Department of Biomedicine and Methods in Medical Diagnostics, Orebro University 70182, SE
1 Department of Biomedicine and Methods in Medical Diagnostics, Orebro University 70182, SE
Source
Indian Journal of Medicine and Healthcare, Vol 2, No 7 (2013), Pagination: 281-291Abstract
The aim of this study was staining of NOD1, NOD2 and CFTR receptors and its visualization by using light and confocal microscopy. Also it describes uses and advantages of confocal microscopy over other techniques, details of cystic fibrosis disease, pathophysiology, clinical features, prevalence, diagnosis and treatment. The results indicated marked expression of CFBE cell lines when visualized under confocal microscopy.Keywords
Confocal Microscopy, Laser Scanning Confocal Microscope, Cystic Fibrosis NOD1, NOD2, CFTRFull Text
References
- Paddock S W (2000). Principles and practices of laser scanning confocal microscopy, Molecular Biotechnology, vol 16(2), 128–149.
- Olympus confocal microscope manufacturers’ webpage [Homepage on internet], Available from: www.olympusfluoview.com/theory/index.html
- Alberts B, Johnson A et al. (2002). Molecular biology of the cell, [Monograph on the Internet] New York: Garland Science, Available from: http://www.ncbi.nlm.nih.gov/books/NBK26880/#A1745
- Lodish H, Berk A et al. (2000). Molecular cell biology, [Monograph on the Internet], New York: W. H. Freeman, 4th edition, Available from: http://www.ncbi.nlm.nih.gov/books/NBK21629/#A1086]
- Lodish H, Berk A et al. (2000). Molecular cell biology. [Monograph on the Internet]. New York: W. H. Freeman, 4th Edn., Available from: http://www.ncbi.nlm.nih.gov/books/NBK26880/#A1722]
- Zieve D, Kaneshiro N K (2010). Pubmed Health, Disease and condition, cystic fibrosis, [Monograph on the Internet], Available from: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001167
- Kumar V, Abbas A K et al. (2004). Robbins and Cotran pathological basis of disease, Elsevier Saunders, 7th Edn., 489–495.
- Narasimhan M, and Cohen R (2011). New and investigational treatments in cystic fibrosis, Therapeutic Advances in Respiratory Disease, [Epub ahead of print], DOI: 10.1177/1753465811398267, Available from: http://tar.sagepub.com/content/early/2011/03/02/1753465811398267
- Roussel L, and Rousseau S (2010). IL-17 primes airway epithelial cells lacking functional Cystic Fibrosis Transmembrane conductance Regulator (CFTR) to increase NOD1 responses, Biochemical and Biophysical Research Communications, vol 391(1), 505–509.
- Cigana C, Curcurù L (2009). Pseudomonas aeruginosa Exploits Lipid a and Muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection, PLoS One, vol 4(12), e8439.
- Donaldson S H, and Boucher R C (2006). Pathophysiology of cystic fibrosis, Ann Nestlé [Engl], vol 64, 101–109, DOI: 10.1159/000095374, Available from: www.karger.com/ane
- Proesmans M, Vermeulen F et al. (2008). What’s new in cystic fibrosis? From treating symptoms to correction of the basic defect, European Journal of Pediatrics, vol 167(8), 839–849.
- Hermanson G T (2008). Bioconjugate techniques: Academic Press, 401–403, Available from: http://books.google.com/books?id=alooWMkRMk0C&dq=FITC+bioconjugate&source=gbs_navlinks_s